SOM230: 61 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
61
Total FAERS Reports
6 (9.8%)
Deaths Reported
42
Hospitalizations
61
As Primary/Secondary Suspect
5
Life-Threatening
2
Disabilities
First Report: 20081028 · Latest Report: 20140423
What Are the Most Common SOM230 Side Effects?
#1 Most Reported
Hyperglycaemia
26 reports (42.6%)
#2 Most Reported
Nausea
10 reports (16.4%)
#3 Most Reported
Diabetes mellitus
10 reports (16.4%)
All SOM230 Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperglycaemia | 26 | 42.6% | 3 | 16 |
| Diabetes mellitus | 10 | 16.4% | 1 | 8 |
| Nausea | 10 | 16.4% | 2 | 6 |
| Vomiting | 6 | 9.8% | 2 | 5 |
Who Reports SOM230 Side Effects? Age & Gender Data
Average age: 53.0 years. Most reports from: DE. View detailed demographics →
Is SOM230 Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 5 | 0 | 3 |
| 2010 | 8 | 0 | 6 |
| 2011 | 12 | 1 | 10 |
| 2012 | 9 | 2 | 8 |
| 2013 | 16 | 2 | 9 |
| 2014 | 5 | 0 | 4 |
What Is SOM230 Used For?
| Indication | Reports |
|---|---|
| Pituitary-dependent cushing's syndrome | 14 |
| Acromegaly | 12 |
| Pancreatic carcinoma | 9 |
| Neuroendocrine tumour | 8 |
Official FDA Label for SOM230
Official prescribing information from the FDA-approved drug label.